Bringing a prophylactic Ebola vaccine to licensure

Informazioni relative al progetto

EBOVAC3

ID dell’accordo di sovvenzione: 800176

DOI 10.3030/800176

Data della firma CE 15 Giugno 2018

Data di avvio 1 Giugno 2018

Data di completamento 30 Settembre 2024

Finanziato da

• SOCIETAL CHALLENGES - Health, demographic change and well-being

Costo totale € 50 979 889,71

Contributo UE € 29 402 655,71

Coordinato da

LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE ROYAL CHARTER
United Kingdom

Risultati finali

Documents, reports (1)

Pilot on integrated solution linking vaccine label to biometric profile

Pubblicazioni

Other (4)

Safety and immunogenicity of the heterologous two-dose Ad26.ZEBOV, MVA-BN-Filo vaccine regimen in healthcare providers and frontliners of the Democratic Republic of the Congo.

Autori: Y Larivière, I Garcia-Fogeda, T Zola Matuvanga et al.
Pubblicato in: 2023
Editore: UAntwerp / UNIKIN
DOI: 10.1093/infdis/jiad350

Parameter estimation in nonlinear mixed effect models based on ordinary differential equations: An optimal control approach

Autori: Clairon, Quentin; Pasin, Chloé; Balelli, Irene; Thiébaut, Rodolphe; Prague, Mélanie
Pubblicato in: HAL Open Science, Numero 1, 2021
Editore: HAL Open Science
DOI: 10.13140/rg.2.2.18016.81920

Researchers’ responsibility in low-resource settings: experiences of an ancillary care policy and practices in a vaccine trial in the Democratic Republic of the Congo

Autori: Gwen Lemey, T Zola Matuvanga, Ynke Larivière, Solange Milolo, Engbu Danoff, Lazarre Bakonga, Emmanuel Esanga, Peter Vermeiren, Vivi Maketa, Junior Matangila, Patrick Mitashi, Pierre Van Damme, Jean-Pierre Van geertruyden , Raffaella Ravinetto, Hypolite Muhindo-Mavoko
Pubblicato in: Research Ethics, 2023
Editore: UAntwerp
DOI: 10.1177/1747016123119413

Rapport final Etude de la résurgence de la Maladie à Virus Ébola dans la région de Nzérékoré par l’équipe du CERFIG-RKI-IRD-UNICEF

Autori: Saez, Almudena Mari, Frederic Le Marcis et al.
Pubblicato in: 2021
Editore: Institute of Research for Development
DOI: 10.13140/rg.2.2.14143.84641

Peer reviewed articles (6)

Setting up an Ebola vaccine trial in a remote area of the Democratic Republic of the Congo: Challenges, mitigations, and lessons learned

Autori: Trésor Zola Matuvanga, Ynke Larivière, Gwen Lemey, Jessie De Bie , Solange Milolo, Rachel Meta, Emmanuel Esanga, Paul Peter Vermeiren , Séverine Thys, Jean-Pierre Van geertruyden , Pierre Van Damme, Vivi Maketa, Junior Matangila , Patrick Mitashi, Hypolite Muhindo-Mavoko
Pubblicato in: Vaccine, 2022, ISSN 0264-410X
Editore: Elsevier BV
DOI: 10.1016/j.vaccine.2022.04.094

Use of Iris Scanning for Biometric Recognition of Healthy Adults Participating in an Ebola Vaccine Trial in the Democratic Republic of the Congo: Mixed Methods Study

Autori: Zola Matuvanga T, Johnson G, Larivière Y, Esanga Longomo E, Matangila J, Maketa V, Lapika B, Mitashi P, Mc Kenna P, De Bie J, Van Geertruyden J, Van Damme P, Muhindo Mavoko H.
Pubblicato in: Journal of Medical Internet Research, Numero 14388871, 2021, ISSN 1438-8871
Editore: Journal of medical Internet Research
DOI: 10.2196/28573

Algorithm for the support of non-related (serious) adverse events in an Ebola vaccine trial in the Democratic Republic of the Congo

Autori: Lemey, Gwen, Ynke Larivière, Trésor Zola, Hypolite Muhindo, Vivi Maketa, Patrick Mitashi, Junior Matangila, Peter Vermeiren, Jessie De Bie, Jean-Pierre Van geertruyden, Pierre Van Damme
Pubblicato in: BMJ Global Health, 2021, ISSN 2059-7908
Editore: BMJ Global Health
DOI: 10.1136/bmjgh-2021-005726

Resurgence of Ebola Virus in 2021 in Guinea Suggests a New Paradigm for Outbreaks

Autori: Keita, Alpha Kabinet, Fara R. Koundouno, Martin Faye, Ariane Düx, Julia Hinzmann, Haby Diallo, Ahidjo Ayouba, Le Marcis, Frédéric et al. 2021.
Pubblicato in: Nature, 2021, ISSN 1476-4687
Editore: Nature
DOI: 10.1038/s41586-021-03901-9

Potential Test-Negative Design Study Bias in Outbreak Settings: Application to Ebola vaccination in Democratic Republic of Congo

Autori: Carl B Pearson, W John Edmunds, Thomas J Hladish, Rosalind M Eggo
Pubblicato in: International Journal of Epidemiology, 2022, ISSN 0300-5771
Editore: Oxford University Press
DOI: 10.1093/ije/dyab172

Open-label, randomised, clinical trial to evaluate the immunogenicity and safety of a prophylactic vaccination of healthcare providers by administration of a heterologous vaccine regimen against Ebola in the Democratic Republic of the Congo: the study protocol

Autori: Ynke Larivière, Trésor Zola, Elke Stoppie, Vivi Maketa, Junior Matangila, Patrick Mitashi, Jessie De Bie, Hypolite Muhindo, Jean-Pierre Van geertruyden, Pierre Van Damme
Pubblicato in: BMJ Open, 2021, ISSN 2044-6055
Editore: BMJ Publishing Group
DOI: 10.1136/bmjopen-2020-046835